Skip to Content

Vaccinex Inc

Rating as of

Company Profile

Business Description

Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline includes VX18 Neurology, VX5 Autoimmune, and others.

1895 Mount Hope Avenue
Rochester, NY, 14620
T +1 585 271-2700
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 49